Ignite Creation Date:
2024-05-06 @ 1:31 AM
Last Modification Date:
2024-10-26 @ 11:05 AM
Study NCT ID:
NCT01822314
Status:
COMPLETED
Last Update Posted:
2024-03-07
First Post:
2013-03-25
Brief Title:
Neoadjuvant Chemotherapy With Nab-paclitaxel in Women With HER2-negative High-risk Breast Cancer
Sponsor:
Fondazione Michelangelo
Organization:
Fondazione Michelangelo
Organization Data
Organization:
Fondazione Michelangelo
Class:
OTHER
Study ID:
FM-12-B01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Fondazione Michelangelo
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None